Fore, score and 28 years ago the "SOFA" scoring system was developed by the EU society of critical care med.  At the same key moment in time the PMX filter was approved by the Japanese medical sytem AND perhaps most importantly the EAA ( Endotoxin Activity Assay ) was invented by our former CEO and his brilliant colleague.  Seems 1994 was a most important moment in the history of our "theranostic" approach to helping the critically ill with Endotoxemic Septic Shock.


I was looking at potential UPdates due and in sum cases...well over-due for our public company.  San Diego was a "science fair" ... NOT an invester conference..our decision to play keep-away with San Diego intel...completely defendable..ask Don ; - )

* Explanation from the FDA and company ( likely our CMO best to explain ) as to why with over 300,000 uses  ( over 200,000 at phase 3 Euphrates start-up  ) the "capacity" of the PMX filter was NOT established before the phase 3 trial began.  If we knew the FDA approved ( 2003 ) EAA diagnostic told us that .4 to .6 was elevated endotoxin levels and over .6 was HIGH, why have .8 be the median EAA starting point for the "per protocol patient population" in the 194 selected patients minus the 16 Canadien sites ALL apparently applying the SHAM filter and NOT the PMX.  "WE" thought patient selection as per PMX or SOC was "random" .  Bear in mind a reported 17% of patients were over .9 and therefore beyond the capacity of the filter.

* Invester presentation - "Coming Soon" ; - )  ... 3 months olde for a company that was $41/share, with a handful of FDA approvals and a "hungry insider appetitte" Cla$$Y

* Explanation from the BoD on the decision to taint / destroy the 6.6M CAD from Baxter Medical by splitting the NO strings attached revenue into 108 tiny pieces ( 9 year a-knewity ) followed by an ANONYMOUS 1.7M CAD charge to "tank the quarter" and begin the now 60 to 70M share "Paper Party"  The number to the Ontario council of accounting to have them explain "arm's length" and "conflict of interest" accounting rules and general practices.

* Update on SAMI rental program ( FDA approved 2018 )  Update on development of DIMI sales in-house training ( FDA approved 2020 )  My cousin saw a small group running the hill at Centennial Park..perhaps our "good people" in training?
*  Heavy SHORTING on next to No US volume on the US OTC PINK sheets, I've never seen a company with a FDA approval trade here..let alone 4 FDA approvals.  Why have we positioned ourselves on the lowest possible exchange platform for over 63 months?
* Updating company filing, NO updates on VP Foster's option / deferred share take and NO update on former Dialco leads profile, gone for 8 months now
* Details from the San Diego conference including the update on the TIGRIS trial from Sobia Khan from Stony Brook.  Bear in mind this site also hosted the completely undisclosed results from the single digit patient CV19 trial attempt
* TIGRIS update on US Trials.gov - last updated Sept.14/21 with only 11 of the now 15 sites actively recruiting.
* Paradime analyst?  appears "MIA", Paradime has not purchased ONE share in over 7 months, they did sell 87K a couple days before the 15 cent event .
* Disclosure of Kellum's last presentation at Vicenza, his Saturday morning appearance at the end of Vicenza remains a "redacted treat" for special invitees
* Ronco and Walker's "keynote addresses" at the TIGRIS pep rally held 3 weeks ago.  It would appear this too, was detail that is best "redacted"
* DISCLOSURE of amendment update for Dialco.  We were told on December 2 2021 that the amendment was to allow patients using the DIMI in home, extended or continued use of the state-of-the-arte device beyond the trial.  We were told this amendemnt would come in mid December..it came two weeks ago and it arrived with NO disclosure.
* 18% absolute efficacy achieved in the phase 3 Euphrates trial ..the subgroup??  This was disclosed 68 months ago..we've yet to recieve ANY detail on this most important figure
* Alter-cyte activity - what is going on with Pittsburgh based Altercyte? 49% owned by Spectral and an additional 2% owned by an undisclosed director.

Seems the swiftest action was the creation of "Dialco" and it's abrupt move away from the Spectral connection.  I was curious about just why Dialco was created so quickly and I suggested to fellow "STIG" members that Dialco allowed for DIMI and SAMI to be "further removed" from the EDTXF ticker symbol...sum scoffed...history tells us that having these approved and black and white type assets attached by a "TAB" has clearly been important on our path to 15 CENTS ( December 2021 )...and that is CAD ( ouch ; - (  )

LOVE the company.."wish I owned more".....

BUT bear in mind..."THEY OWN IT ALL" ...in 2008 a total of 1.2M shares traded for the entire year ( 365 days ), since that time, ALL share creation has remained within the "inner circle of trust" ...they have been "placed" ... NOT offered for public consumption.

ALL in my most humble, yet rather most educated retail shareholder opinion.  Do your own due diligence and feel free to challenge where inconsistencies are discovered.  Consult a real pro on matters of $108 ( inflation adjusted ) or greater.  This afterall is purely spectralative- IMHEO

Bon appy,
Tom